| GC37760-10mg |
|
201341-05-1 |
|
0 |
C19H30N5O10P |
|
|
|
| GC37760-10mM (in 1mL DMSO) |
|
201341-05-1 |
|
0 |
C19H30N5O10P |
|
|
|
| GC37759-100mg |
|
1392275-56-7 |
Tenofovir alafenamide hemifumarate
|
0 |
C21H29N6O5P.1/2 C4H4O4 |
|
|
|
| GC37759-50mg |
|
1392275-56-7 |
Tenofovir alafenamide hemifumarate
|
0 |
C21H29N6O5P.1/2 C4H4O4 |
|
|
|
| GC37759-10mg |
|
1392275-56-7 |
Tenofovir alafenamide hemifumarate
|
0 |
C21H29N6O5P.1/2 C4H4O4 |
|
|
|
| GC37759-5mg |
|
1392275-56-7 |
Tenofovir alafenamide hemifumarate
|
0 |
C21H29N6O5P.1/2 C4H4O4 |
|
|
|
| GC37759-10mM (in 1mL DMSO) |
|
1392275-56-7 |
Tenofovir alafenamide hemifumarate
|
0 |
C21H29N6O5P.1/2 C4H4O4 |
|
|
|
| GC37758-100mg |
|
379270-38-9 |
Tenofovir alafenamide fumarate
|
0 |
C25H33N6O9P |
|
|
|
| GC37758-50mg |
|
379270-38-9 |
Tenofovir alafenamide fumarate
|
0 |
C25H33N6O9P |
|
|
|
| GC37758-10mg |
|
379270-38-9 |
Tenofovir alafenamide fumarate
|
0 |
C25H33N6O9P |
|
|
|
| GC37758-5mg |
|
379270-38-9 |
Tenofovir alafenamide fumarate
|
0 |
C25H33N6O9P |
|
|
|
| GC37758-10mM (in 1mL DMSO) |
|
379270-38-9 |
Tenofovir alafenamide fumarate
|
0 |
C25H33N6O9P |
|
|
|
| GC37757-50mg |
|
1572583-29-9 |
Teneligliptin hydrobromide hydrate
|
0 |
C22H30N6OS |
|
|
|
| GC37757-10mg |
|
1572583-29-9 |
Teneligliptin hydrobromide hydrate
|
0 |
C22H30N6OS |
|
|
|
| GC37756-20mg |
|
335299-59-7 |
|
0 |
C16H18N4NaO3S |
|
|
|
| GC37756-10mg |
|
335299-59-7 |
|
0 |
C16H18N4NaO3S |
|
|
|
| GC37756-5mg |
|
335299-59-7 |
|
0 |
C16H18N4NaO3S |
|
|
|
| GC37756-1mg |
|
335299-59-7 |
|
0 |
C16H18N4NaO3S |
|
|
|
| GC37755-50mg |
|
1033805-22-9 |
LX1606 (Telotristat ethyl)
|
0 |
C27H26ClF3N6O3 |
|
|
|
| GC37755-10mg |
|
1033805-22-9 |
LX1606 (Telotristat ethyl)
|
0 |
C27H26ClF3N6O3 |
|
|
|
